The poor prognosis of pancreatic cancer patients with comorbid diabetes is mechanistically linked to the expansion of senescent endothelial cells within the TME and their secretion of the TGF-β (transforming growth factor-β) family SASP factor INHBB (inhibin-β B subunit) [56]. Here, INHBB is linked to diabetes mellitus.